Intravitreal ranibizumab improves macular sensitivity in patients with central retinal vein occlusion and macula edema

Intravitreal ranibizumab improves macular sensitivity in patients with central retinal vein occlusion and macula edema

Abstract Background Patients with central retinal vein occlusion (CRVO) and macular edema often are treated by intravitreal ranibizumab injection (IRI). The role of changes in macular sensitivity in the positive effects of IRI on visual functions is unclear. Therefore, we assessed the relationship b...

Full description

Bibliographic Details
Main Authors: Taro Otawa, Hidetaka Noma, Kanako Yasuda, Akitomo Narimatsu, Masaki Asakage, Akina Tanaka, Hiroshi Goto, Masahiko Shimura
Format: Article
Language:English
Published: BMC 2022-06-01
Series:BMC Ophthalmology
Subjects:
Central retinal vein occlusion
Macular edema
Ranibizumab
Macular sensitivity
Online Access:https://doi.org/10.1186/s12886-022-02478-9

Internet

https://doi.org/10.1186/s12886-022-02478-9

Similar Items